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 Raman spectroscopy is an effective
method for the differentiation of
immune cells.
 Cell lines and primary cells in both
resting and activated states were
identified.
 Spectral signatures of molecular
expression aligned with reference
measurements.
 Potential spectral biomarkers that
elucidate the spectral classification
were identified.
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a b s t r a c t
Activation and proliferation of immune cells such as lymphocytes and monocytes are appropriate inflam-
matory responses to invading pathogens and are key to overcoming an infection. In contrast, uncon-
trolled and prolonged activation of these cellular signalling pathways can be deleterious to the body
and result in the development of autoimmune conditions. The understanding of cellular activatory status
therefore plays a significant role in disease diagnosis and progression. Conventional automated
approaches such as enzyme linked immunosorbent assays (ELISA) and immune-labelling techniques
are time-consuming and expensive, relying on a commercially available and specific antibody to identify
cell activation. Developing a label-free method for assessing molecular changes would therefore offer a
quick and cost-efficient alternative in biomedical research. Here Raman spectroscopy is presented as
an effective spectroscopic method for the identification of activated immune cells using both cell lines
and primary cells (including purified monocyte and lymphocyte subgroups and mixed peripheral blood
mononuclear cell (PBMC) populations) obtained from healthy donors. All cell lines and primary cells were
exposed to different stimulants and cellular responses confirmed by flow cytometry or ELISA. Machine
learning models of cell discrimination using Raman spectra were developed and compared to reference
flow-cytometry, with spectral discrimination levels comparing favourably with the reference method.
Spectral signatures of molecular expression after activation were also extracted with results demonstrat-
ing alignment with expected profiles. High performance classification models constructed in these in-
vitro and ex-vivo studies enabled identification of the spectroscopic discrimination of immune cell sub-
types in their resting and activated state. Further spectral fitting analysis identified a number of potential
spectral biomarkers that elucidate the spectral classification.
 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.saa.2020.119118
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1. Introduction
Inflammation is a recognised hallmark of many clinical disor-
ders and involves a coordinated response of innate and adaptive
immune cells against invading pathogens [1]. The innate immune
response provides a rapid and non-specific reaction to the presence
of foreign pathogens but lacks memory while the adaptive immune
response which is characterised by a slow, challenge-specific
response, creates an immunological memory after an initial
encounter with a specific pathogen. The innate immune response
is mediated by innate immune cells which include mast cells, nat-
ural killer (NK) cells, eosinophils, basophils and phagocytic cells
(including monocytes, macrophages, neutrophils, and dendritic
cells (DCs)). The adaptive immune response is mainly mediated
by T and B lymphocytes.
Previously, it had been considered that the innate and adaptive
arm of the immune network were independent defence mecha-
nisms, with the innate immune system recognising foreign patho-
gens non-specifically [2]. It has long been accepted that there is
significant bidirectional cooperativity between the innate and
adaptive immune response, with many studies describing their
crosstalk and the potential to exploit this to develop therapies
for various diseases [2–4]. In a functional immune system, the bio-
chemical events which transduce pro-inflammatory signals from
infected tissue cause the recruitment of monocytes from the bone
marrow. These monocytes differentiate into phagocytic macro-
phages and along with DCs, enter the lymph nodes. The interaction
between antigen presenting cells (APCs) such as DCs, and naïve T
cells, enhances the adaptive immune response against the patho-
gen [5]. Cell activation is an early and crucial step in mounting
an antigen-dependent or independent stimulation of adaptive
and innate immune cells and triggering signalling cascades as a
defence mechanism [6]. The intracellular signalling events trig-
gered eventually result in morphological and molecular changes
inside the cell and on its surface [7,8].
In general standard reference methods such as ELISA, flow
cytometry and confocal microscopy are used to monitor the acti-
vation status of immune cells by measuring cytokines released or
the expression of specific molecules of interest [9]. These
approaches require cellular fixation, chemical staining and fluo-
rescent labelling with conjugated antibodies which are invasive
and may interfere with biological processes, thus potentially pre-
venting the accurate investigation of cellular behaviour in a dis-
ease state [10].
Raman spectroscopy is a non-invasive, label-free optical tech-
nique capable of decoding the biochemical signature of cells and
tissues in-situ. It relies on the intrinsic scattering characteristics
of the molecular composition of the cell under investigation and
provides a chemical fingerprint of the cell without the requirement
of extrinsic labels such as conjugated antibodies, stains or radioac-
tive labels. This has allowed it to be employed for the development
of methods for the automated discrimination of immune cell lines
and their subpopulations [10–13], the differentiation of cell lines
[14] and drug-cell interactions [10,15], amongst other applications.
While examination of the effect of leucocyte stimulation on Raman
spectra has been performed previously, no work has compared and
contrasted these signals both in immune cell lines and primary
leucocytes (both purified cell subgroups and peripheral blood
mononuclear cell (PBMC) populations).
In this study Raman spectroscopy was employed for the analy-
sis of immune cells in both resting and activated states using in-
vitro and ex-vivo models, with a specific aim to develop a spectral
model of immune cell activation both within leucocyte subpopula-
tions and mixed PBMCs.
2. Materials and methods
2.1. Ethical approval
Ethical approval was awarded by the TU Dublin Ethics Commit-
tee (approval REC 16-92) for the conduct of this study. Two 3.5 mL
sodium citrate whole blood samples were obtained from each
healthy volunteer who had provided informed consent.
2.2. Cell culture
Cells of the Raji B line were a gift from and Dr. David Brayden
(University College Dublin, Ireland) while Jurkat T cells and THP-
1 monocytes were obtained from existing laboratory stocks. The
standard protocol from American Type Culture Collection (ATCC)
was followed for the resuscitation of frozen cell lines and their cul-
ture. All cell lines were cultured in suspension in Roswell Park
Memorial Institute medium 1640 (RPMI); (Sigma Aldrich, Dublin,
Ireland), supplemented with 10% foetal bovine serum (FBS) (Sigma
Aldrich, Dublin, Ireland) at 37 C in a humidified atmosphere with
5% CO2.
PBMCs were isolated from whole blood by gently mixing 3 mL
of Dulbecco’s modified phosphate buffered saline (DPBS) with
3 mL of blood. This mixture was then overlaid onto 6 mL of Histo-
paque and separated by centrifugation at 400g for 30 min at 18 C
with brakes off. The PBMC layer was pipetted off and the super-
natant discarded. These cells were re-centrifugated and washed
in DPBS three times before the pellet was resuspended in RPMI
supplemented with 12.5% FBS and cultured at 37 C, 5% CO2.
2.3. Cell treatment
All cell lines were seeded at a density of 5  105 cells/mL in a
final volume of 2 mL in a 6-well plate (Nunc, Fisher Scientific, Ire-
land) for treatment, with parallel samples prepared for flow
cytometry and Raman spectroscopy. Jurkat T cells were treated
with phytohaemagluttinin (PHA) (10 mg/mL) (Sigma Aldrich,
Dublin, Ireland) for 24 hr [16] and Raji B cells with 20 ng/mL phor-
bol 12-myristate 13-acetate (PMA, Sigma Aldrich, Dublin, Ireland)
and 0.3 mM Ionomycin (Sigma Aldrich, Dublin, Ireland) for 48 hr
[17]. THP1 monocytes were treated with 100 nM PMA at 37 C in
5% CO2 for 72 hr to induce macrophage differentiation [18]. After
the exposure period had elapsed, samples were washed with the
appropriate media after centrifugation at 300g for 5 min.
PBMCs were treated with either PHA (10 mg/mL for 72 hr) or LPS
(0.1 mg/mL for 24 hr). Purified monocyte and lymphocyte subpop-
ulations were obtained from each whole blood sample using the
EasySep Direct Human T cell, B cell and monocyte isolation kits
(Stemcell Technologies, Grenoble, France) following the manufac-
turer’s recommended protocol. This step was performed within 4
hr of blood collection. All primary cells were seeded at a density
of 5  105 cells/mL in a 24-well plate (Nunc, Fisher Scientific, Ire-
land). T lymphocytes were treated with 10 mg/mL PHA for 72 hr
[16], B lymphocytes with 0.08 mg/mL IL-4 and 2 mg/mL CD40 ligand
(CD-40L) for 48 hr [19] and monocytes with 0.1 mg/mL lipopolysac-
charide (LPS; Sigma Aldrich, Dublin, Ireland) for 24 hr [20]. At the
end of the treatment time, cells were washed with DPBS after cen-
trifugation at 300g for 5 min and their response assessed using
flow cytometry, ELISA and Raman spectroscopy.
2.4. Flow cytometry
Flow cytometry was conducted using a BD Biosciences Accuri
C6 Flow Cytometer (Becton Dickinson, Oxford, UK). The washed
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cell pellet was blocked in PBS solution supplemented with 2% FBS
for 30 min at 4 C. After blocking, cells were resuspended in 10 mL
of conjugated monoclonal antibody and 200 mL of blocking solution
(PBS supplemented with 2% FBS) for 30 min at 4 C. Cell purity was
measured with fluorescent staining for monoclonal antibodies for
each leucocyte subtype (anti-human CD14 as a monocyte marker
(PE, Clone: 63D3), anti-human CD3 as a T cell marker (FITC, Clone:
OKT3), anti-human CD19 as a B cell marker (PE, Clone: HIB19)) ver-
sus a general leucocyte marker (anti-human CD45 (APC, Clone:
HI30) (Medical Supply Co. Ltd, Dublin, Ireland)). The mean fluores-
cence intensity (MFI) of anti-human CD69 (FITC, Clone: FN50)
(Beckton Dickinson BioSciences, Dublin, Ireland) was measured
to determine the levels of lymphocyte activation. Cells were
washed and resuspended in 200 mL of PBS to remove unbound anti-
body prior to flow cytometry measurements. A minimum of 10,000
cell events per sample were recorded. Unwanted debris and cell
aggregates were excluded from the analysis using proper gating
based on forward (FSC) and side scatter (SSC) characteristics.
2.5. Enzyme linked immunosorbent assay
ELISA was used to measure the levels of cytokine expression in
both in-vitro and ex-vivo experiments. In all cases, the supernatant
of each sample was collected and stored at 80 C for further anal-
ysis. The expression of TNF-a within the culture media was
assessed using a human TNF-a ELISA MAX deluxe kit (BioLegend,
Dublin, Ireland) following the manufacturer’s recommended pro-
tocol. The absorbance of each sample was measured using a Spec-
traMax M3 Spectrometer/Plate Reader at 450 nm and 570 nm.
2.6. Raman spectroscopy
Cultured cell samples were washed and fixed using 2%
paraformaldehyde (PFA) in PBS. Fixed cells were drop cast onto cal-
cium fluoride (CaF2, Crystan Ltd, Dorset, UK) slides and then
washed three times with deionised water. The slides were allowed
to air dry for 30 min and were stored in a desiccator at room tem-
perature until the time of measurement.
Raman spectra were acquired with a Horiba Jobin-Yvon LabRam
HR 800 system using a 532 nm laser excitation and a diffraction
grating of 600 lines/mm, which provided a spectral resolution of
~2 cm1. The excitation laser power (~12 mW) was delivered via
a  100 objective (MPlanN, Olympus, numerical aperture
(NA) = 0.9) giving a spot size of diameter ~0.7 mm. The confocal
hole diameter was set to 150 mm and the spectra were recorded
with a 20 s integration time averaged over three accumulations
over the fingerprint region from 400 to 1800 cm1. Spectra of thirty
to fifty cells were recorded for each sample. Each spectrum was
recorded from an individual cell with a 4  4 lm raster scan of
the centre of each cell including both its nucleus and cytoplasm.
All samples were measured within two weeks of slide preparation.
2.7. Spectral preprocessing and analysis
Raman spectral processing algorithms were generated in-house
and implemented within the R-based statistical software (Version
1.0.153). Daily wavenumber calibration was performed using the
520.8 cm1 of silicon while multiple calibration spectra of 1,4-Bis
(2-methylstyryl) benzene (Sigma Aldrich, Dublin, Ireland) and of
the NIST standard SRM 2245 were recorded as a reference before
each sample acquisition for wavenumber and intensity calibration
in pre-processing.
Spectra were then smoothed (Savitsky-Golay filtration employ-
ing a 5th order interpolation polynomial with a window of 15
points), baseline corrected (subtraction of a heavily smoothed
spectrum of the sample created using a Savitsky-Golay filter from
the sample spectrum followed by a rubberband baseline correc-
tion) and vector normalised. Finally outliers were removed (using
Rao’s statistic with Grubb’s test). Principal Component Analysis
(PCA) Linear Discriminant Analysis (LDA) models of the spectral
data were then developed. Briefly, PCA reformulates the highly
covariant spectral variables within matrices of Raman spectra into
a new set of mutually orthogonal bases (principal components
(PCs) or latent variables (LVs)) and scores. LDA then defines a dis-
criminating line or hyperplane using combinations of PC scores
which results in maximum class separation. This approach has
been used previously to develop spectral classifiers for disease
diagnosis and stratification [21,22]. Here PCA-LDA models were
optimised for model performance and complexity (LV) using leave
one spectrum out cross-validation (LOOCV). Model performance
was expressed in terms of sensitivity and specificity. To enable
deeper insight into the biochemical origin of spectral discrimina-
tion, classic-least squares (CLS) fitting of spectra was employed.
A Raman spectrum of cells may be modelled as a linear combina-
tion of spectra of molecular species including protein, lipids and
nucleic acid, which exist in the cell at different relative concentra-
tions [23]. Here CLS was performed in Matlab (Version:
9.2.0.556344, R2017a) (Mathworks Inc.) using spectra of pure bio-
chemical species listed in Table 1. Each reference biochemical was
purchased from Sigma Aldrich (Ireland) and their spectra were
recorded without further purification Examples of these spectra
are provided in Supp Figs. 1–3.
Table 1
Pure reference molecules used for CLS analysis in this study.
Category Pure reference molecules
1) Amino acids Alanine, L-Arginine monohydrochloride, L-Asparagine, L-Aspartic acid, L-Cysteine, L-Cysteine hydrochloride anhydrous, L-Cystine, L-
Glutamic acid, L-Glutamine, L-Histidine monohydrochloride, L-Leucine, L-Lysine monohydrochloride, L-Methionine, L-Proline, L-Serine, L-
Threonine, L-Valine, L-Phenylalanine, Tryptophan, L-Tyrosine, L-Citrulline, Glycine, Isoleucine, D Aspartic acid, Taurine, Spermine
2) Protein and related
compounds
Actin, Haemoglobin, Interleukin-8, Clusterin, Ubiquitin, Apolipoprotein E4, Histone, Tumour necrosis factor alpha, Apotransferrin, Lectin,
Cytochrome C
3) Nucleic acids and
nucleobases
RNA, DNA, Guanine, Cytosine, Thymine, Uracil, Thymidine, Adenine, Deoxyuridine, Methylcytosine
4) Growth factors Keratinocyte growth factor, Epidermal growth factor
5) Lipids and fatty acids Ceramide, Ceramide 2, Ceramide 14, Ceramide 18, Ceramide 22, Ceramide 24, Linoleic acid, Linolenic acid, Oleic acid, L-
Phosphatidylcholine, L-Phosphatidylserine, L- Phosphatidylinositol, L-Phosphatidylethanolamine, Palmitic acid, Sphingomyelin, Stearic
acid, Triglyceride
6) Enzymes Carbonic anhydrase, Catalase, Alkaline phosphatase, b-Glucuronidase, Lysozyme, L-Lactate dehydrogenase, DNase 1
7) Carbohydrate Glucose, Glycogen, N-acetyl D-glucosamine
8) Vitamins Biotin, Sodium L-ascorbate, Vitamin C, Vitamin E, Ascorbic acid
9) Other molecules b-Carotene, Uric acid, Creatinine, Xanthine, Lipoic acid, L-Glutathione oxidised, L-Glutathione reduced, Creatinine Anhydrous, Hyaluronic
acid, N-acetyl L-cysteine
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2.8. Statistical analysis
An unpaired, two-tailed, Students t-test was used to ascertain
whether statistical significance existed in differences between con-
trol and treated samples in respect of MFI and CLS fitting coeffi-
cients. This was performed within the R environment (Version
1.0.153) and in Matlab (Version: 9.2.0.556344, R2017a) (Math-
works Inc.).
3. Results
3.1. Discrimination of spectral signatures of immune cell lines in
resting and activated states
Combined results from flow cytometry, ELISA (where relevant)
and Raman spectroscopy are depicted in Figs. 1–3 respectively for
the T lymphocyte (Jurkat), B lymphocyte (Raji-B) and monocyte
(THP-1) cell lines. PHA is widely used as an agonist for adaptive
immune cells (mainly T lymphocytes) [24]. PHA mainly induces
lymphocyte proliferation and evokes cellular compositional
changes through the protein tyrosine kinase (PTK) signalling trans-
duction pathway [24,25]. PMA is a specific activator of protein
kinase C and hence nuclear factor-kappa-B (NFjB), which has a
key role in the inflammatory response while ionomycin is a cal-
cium ionophore which can create similar effects to those seen with
TCR-induced phospholipase C activation. Activation of the T and B
lymphocyte cell line post treatment was confirmed via a histogram
shift – black line (Figs. 1A, 2A respectively) and a significant
increase in CD69 expression ((Figs. 1B, 2B respectively), while acti-
vation of the THP1 monocyte line was confirmed by a statistically
significant increase in TNF-a release post PMA treatment (Fig. 3A).
The Raman mean spectra, PCA scores and the results of CLS fit-
ting of spectra are shown in each figure. The assignment for the
individual Raman band of interest is listed (Table 2). In the case
of the T lymphocyte cell line the mean Raman spectra of untreated
and PHA treated Jurkat T cells exhibited many similar features;
however some subtle variations in modes associated with protein
were observed (Fig. 1C). A PCA-LDAmodel was optimised to a com-
plexity of 3 LVs and performed with 91% sensitivity and 70% speci-
ficity, respectively, owing to the high intra-sample variability seen
in PCA scores within Fig. 1D. CLS analysis identified differentiated
spectral contributions from actin, apotransferrin, arachadonic acid,
DNA, histone, and proteinase-K (Fig. 1E).
Similarly, in Fig. 2, mean Raman spectra demonstrated that
slight alterations in the PMA and Ionomycin treated Raji B lympho-
cytes occurred in the regions associated with nucleic acid and pro-
tein content of the samples (780, 876, 1094, 1315, 1338, 1002,
1576 cm1) [26] (Fig. 2C). PCA-LDA classification of stimulated
from resting Raji B lymphocytes was optimised using the first 6
LVs, performing with sensitivity and specificity of 95.2% and
81.6%, respectively (see PCA scores in Fig. 2D). The CLS fitting of
spectra pre and post treatment identified several differentiated
molecular species including actin, apotransferrin, arachidonic acid,
carbonic anhydrase, DNA, histone, linoleic acid, linolenic acid,
Fig. 1. PHA treatment of Jurkat T cells caused an increase in CD69 expression. (A) The overlay histogram plot shows the expression of CD69 in untreated (red line) and PHA
treated cells (black line), (B) Mean Fluorescence Intensity (MFI) produced by CD69 expression on untreated and PHA treated Jurkat cells. Data is normalised to untreated cells
and is expressed ± SD (n = 3), (C) Mean and standard deviation of Raman spectra of untreated and PHA treated Jurkat T cells, (D) PCA score plot of Raman spectra of Jurkat T
cells in the absence or presence of PHA (10 mg/mL). Percentage label on each axis in (D) indicates the variance associated with the principal component (PC) outlined for the
discrimination of untreated and PHA activated Jurkat T cells. Covariance ellipses (95% confidence limit) in (D) are shown for each class. (E) The normalised component fit of
pure reference molecules from CLS fitting of Raman spectra of untreated and PHA treated Jurkat T cells. Data is normalised to untreated Jurkat cells and is expressed ± SE
(n = 3). Significance is shown in (E) by (*) and indicates a significance of *p < 0.05, **p < 0.001 and ***p < 0.0001.
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phosphatidyl-choline (denoted ‘P-choline’ in the figure) and RNA
(Fig. 2E). Spectral differences in the intensities of the signatures
of DNA, histone and Phosphatidyl-choline was observed.
The mean Raman spectra (Fig. 3B) of untreated and PMA treated
THP-1 cells exhibited slight alterations in regions associated with
protein (1002, 1208, 1250 cm1), nucleic acid (780, 827, 1094,
1340, 1578 cm1) and lipid bands (1300, 1444, 1656 cm1),
although it is hard to see all of these alterations macroscopically.
Further in a PCA-LDA model spectra, PMA treated and resting
THP1 monocytes were also strongly differentiated as seen in the
mean raman spectra (Fig. 3B) and PC scores with a model opti-
mised at 2 LVs and a performance of 91% sensitivity and specificity
(Fig. 3C). CLS analysis (Fig. 3D) identified a host of significant dif-
ferentiated spectra signatures including those of actin, apotransfer-
rin, arachidonic acid, DNA, histone, L-alpha phosphatidylcholine,
oleic acid, phosphatidyl-ethanolamine (denoted ‘P-ethanolamine’
in the figure), RNA, and TNF-a, in partial agreement with the ELISA
result here.
3.2. Differentiation of spectral signatures in purified primary immune
cell subtypes in resting and activated states
In the ex-vivo model high cell purities were achieved following
negative selection with a mean purity level of 95.4% (range: 94.4–
96.2%) for T lymphocytes, 95.6% (range: 92–98.3%) for B lympho-
cytes and 95.2% (range: 94–97.5%) for monocytes. CD-40L is a
ligand which binds to the cellular membrane resulting in B cell
specific stimulation, while IL-4 is a cytokine which stimulates B
cell proliferation. LPS is recognised by TLR4 which is present on
monocytes and macrophages and recruits the transcription factor
NFjB into the nucleus which leads to the production of proinflam-
matory cytokines such as TNF-a, IL-6 and IL-8 [9].
Activation of T and B lymphocytes, as measured via CD69
expression, demonstrated a histogram shift (Figs. 4A, 5A) with a
15-fold and 5-fold increase in the observed MFI by cell type,
respectively, though only the former measurement was found to
be statistically significant at p < 0.05 (Fig. 4B, 5B). Treatment of
THP1 monocytic cells with LPS was found to induce a 5-fold
increase in TNF-a release (Fig. 6A).
The mean Raman spectra of untreated and PHA-activated T
lymphocytes exhibit strongly differentiating bands in the regions
associated with nucleic acid and protein (Fig. 4C). Spectral discrim-
ination of stimulated primary T lymphocytes was found to be
strong (see PCA scores in Fig. 4D) where a PCA-LDA model opti-
mised to 2 LVs was found to perform with 90.9% and 98.5%, respec-
tively (Fig. 4D). CLS fitting identified a number of strongly
differentiated spectral features including those of apotransferrin,
arachadonic acid, carbonic anhydrase, DNA, and phosphatidyl-
choline (denoted ‘P-choline’ in the figure), with the levels of
phosphatidyl-choline strongly altered (Fig. 4E).
Stimulated primary B lymphocytes did not demonstrate simi-
larly strong spectral discrimination from the untreated cells
(Fig. 5C), where a PCA-LDA model was optimised to a complexity
of 6LVs and performed with a sensitivity and specificity of 89.9%
and 81%, respectively (Fig. 5D). This agrees with the non-
significant finding in the MFI fold change flow cytometry results
Fig. 2. PMA and ionomycin treatment of Raji B cells caused an increase in CD69 expression. (A) The overlay histogram plot shows the expression of CD69 by untreated (green
line) and treated cells (black line). (B) Mean Fluorescence Intensity (MFI) produced by CD69 expression on untreated and PMA and ionomycin treated Raji B cells. Data is
normalised to untreated cells and is expressed ± SD (n = 3), (C) Mean and standard deviation of Raman spectra of untreated and PMA and ionomycin treated Raji B cells, (D)
PCA score plot of Raman spectra of control and PMA and Ionomycin treated Raji B cells. Percentage label on each axis in (D) indicates the variance associated with the
principle component (PC) outlined for the discrimination of untreated and PMA and Ionomycin treated Raji B cells. Covariance ellipses (95% confidence limit) in (D) are shown
for each class. (E) The normalised component fit of pure reference molecules from CLS fitting of Raman spectra of untreated and PMA & Ionomycin treated Raji B cells. Data is
normalised to untreated cells and is expressed ± SE (n = 3). Significance is shown by (*) and indicates a significance of **p < 0.001 and ***p < 0.0001.
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suggesting cells may have only been partially activated. The distri-
bution of LDA scores (Fig. 5D) clearly demonstrated the intergroup
variance which exists between unstimulated and CD40L and IL-4
stimulated B lymphocytes according to linear discriminant LD1.
The CLS fitting analysis likewise (Fig. 5E) identified only TNF-a
and DNA with strongly altered spectral intensities after
stimulation.
Finally, the mean Raman spectra of untreated and LPS stimu-
lated monocytes (Fig. 6B), purified from whole blood drawn from
healthy volunteers, exhibited slight alterations in regions associ-
Fig. 3. (A) PMA (100 nM) treatment of THP-1 cells caused an increase in TNF-a production. Data is expressed ± SD, (n = 3), (B) Mean and standard deviation of Raman spectra
of untreated and PMA treated THP-1 cells, (C) PCA score plot of Raman spectra of control and PMA treated THP-1 cells. Percentage label on each axis in (C) indicates the
variance associated with the principle component (PC) outlined for the discrimination of untreated and PMA treated THP-1 cells. Covariance ellipses (95% confidence limit) in
(C) are shown for each class. (D) Normalised component fit of pure reference molecules from CLS fitting of Raman spectra of untreated and PMA treated THP-1 cells. Data is
normalised to untreated THP-1 cells and is expressed ± SE (n = 3). Significance is shown by (*) and indicates a significance of *p < 0.05 and ***p < 0.0001.
Table 2
Raman band assignments for some typical vibrations associated with biological specimens.
Frequency (cm1) Assignment Frequency (cm1) Assignment
596 Phosphatidylinositol 1126 CAN stretch (protein)
618 CAC twisting (protein) 1156 CAC, CAN stretch (protein)
646 CAC twisting mode of tyrosine 1194 Nucleic acids and phosphates
678 Guanine ring breathing 1252 Guanine, cytosine
725 Adenine 1280 Amide III
746 Thymine 1300 Fatty acids
780 Uracil ring breathing 1320 CH deformation (proteins)
Guanine
790 OAPAO stretching DNA 1373 Thymine, Adenine, Guanine
852 Proline, hydroxyproline, tyrosine 1449 CH2 bending mode of proteins & lipids
935 CAC stretching mode of proline & valine 1464 Lipids
968 Lipids 1510 Adenine ring breathing
973 CAC backbone (protein assignment) 1552 Tryptophan
980 CAC, @CH stretching (proteins, lipids) 1576 Guanine
1003 Phenylalanine 1650–1680 Amide I
1058 Lipids 1724 Ester group
1096 PO2 in nucleic acids 1757 C@O (lipid)
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ated with nucleic acid and protein bands. The differentiation
between the spectra of primary monocytes after LPS treatment
was reasonably strong with a PCA-LDAmodel optimised to the first
six PCs and delivering a sensitivity of 95.2% and specificity of 80.5%
(see PCA scores in Fig. 6C). CLS fitting analysis (Fig. 6D) identified
significant changes in arachidonic acid, DNA, histone, linolenic acid
and phosphatidyl-ethanolamine (denoted ‘P-ethanolamine’ in the
figure) for the discrimination between the spectra of each class
(Fig. 6D).
3.3. Differentiation of spectral signatures of PBMCs in resting and
activated states
Within the whole PBMC population, CD69 expression exhibited
a histogram shift and a 6-fold increase was observed in the MFI of
CD69 following PHA treatment when normalised to untreated cells
(Fig. 7A and B), confirming an activation signal which was found to
be statistically significant. Similarly ELISA measurements of TNF-a
increased 6-fold post LPS treatment, confirming TLR4 engagement
and increasing cytokine production (Fig. 8A), which was also found
to be statistically significant.
Although not always macroscopically evident, the mean Raman
spectra of untreated and PHA treated PBMCs showed variation in
modes associated with nucleic acid and protein (Fig. 7C). Spectral
discrimination (see PCA scores in Fig. 7D) was strong in the PHA
stimulated cells, with PC scores well separated, while a PCA-LDA
model was optimised to the first two LVs, delivering sensitivities
and specificities of 97.1% and 97.7%, respectively. The CLS fitting
analysis identified the spectral signatures of arachidonic acid, car-
bonic anhydrase, DNA, histone, proteinase-K, RNA and TNF-a as
being differentiated to a statistically significantly degree between
untreated and stimulated samples (Fig. 7E).
The mean Raman spectra of untreated and LPS treated PBMCs is
showin in Fig. 8B. Similarly a PCA-LDA model developed on the
spectra of the LPS stimulated PBMC sample was optimised to 3
LVs delivering a sensitivity of 100% and specificity of 90.2% (see
PCA scores in Fig. 8C). CLS fitting analysis identified apotransferrin,
arachidonic acid, DNA and histone as statistically significantly
altered relative to the control (Fig. 8D).
4. Discussion
In general the classification models based on spectral signatures
of activated versus resting leucocytes exhibit discrimination per-
formances which align with the level of activation measured by
reference methods. Additionally several features regarding the
spectral profiles of activated and resting leucocyte subtypes have
emerged.
In the first observation it appears that the differentiation
between spectral profiles of resting and stimulated cells depends
both on the cell type and the simulant itself. Both the Jurkat T cells
and primary T cells displayed decreased DNA and histone levels.
Upon T cell receptor (TCR) ligand engagement [27,28] a generalised
increase in protein phosphorylation is seen, along with a reorgan-
isation of the cytoskeleton and decondensation of nucleic acid
within the nucleus of the activated cell [7,25,29–32] which may
account for these findings. An increased spectral fit for apotransfer-
rin was also found in both Jurkat T cells and primary T cells upon
activation. Previously it has been reported that when stimulated,
T cells can synthesise and secrete transferrin [33–35]. An increase
in the levels of proteinase-K was observed in Jurkat T cells in which
Fig. 4. PHA treatment of T lymphocytes causes an increase in CD69 expression. (A) The overlay histogram plot shows the expression of CD69 on untreated (red line) and PHA
treated T lymphocytes (black line). (B) MFI produced by CD69 expression on untreated and PHA treated T lymphocytes. Data is normalised to untreated cells and is
expressed ± SD (n = 3). (C) Mean and standard deviation of Raman spectra of untreated and PHA treated T lymphocytes. (D) PCA score plot of Raman spectra of untreated and
PHA treated primary T lymphocytes. Percentage label on each axis in (D) indicates the variance associated with the PC outlined for the discrimination of untreated and PHA
treated T lymphocytes. Covariance ellipses (95% confidence) in (D) are shown for each class. (E) Normalised component fit of pure reference molecules from CLS fitting of
Raman spectra of untreated and PHA treated T lymphocytes. In (E) data is normalised to untreated T lymphocytes and is expressed ± SE (n = 3). Significance is shown by (*)
and indicates a significance of *p < 0.05, and ***p < 0.0001.
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the proteolytic activity of proteinase-K is known to increase post
PHA treatment due to an increase in intracellular calcium ion
(Ca2+) levels promoting downstream cell proliferation [36,37]. This
feature was not observed in primary T cells. Conversely the
increased levels of phosphatidyl-choline observed in primary T
cells, implying increased lipid synthesis as a result of increased cell
proliferation [38], is not seen in the Jurkat T cell line, nor is the
increased signature of carbonic anhydrase, whose maintenance of
intercellular pH level is required for cellular proliferation [39].
In the model of B cell activation two separate stimulants for B
cells were employed. Both the Raji-B cell line and primary B cells
displayed decreased spectral profiles for DNA levels (Figs. 2E and
5E) post stimulation, again implying association with the decon-
densation of nucleic acid within the nucleus in response to inflam-
matory signalling within the cell [7,40]. It is known that the
combination of PMA and Ionomycin stimulates protein kinase C
(PKC) and raises the level of Ca2+ [17], leading to activation of
the MAP Kinase superfamily and nuclear translocation of transcrip-
tion factors such as NFjB resulting in an increase in the protein
synthesis rate which ultimately promotes cell proliferation
[17,41]. While this could explain the increased contribution of
phosphatidyl-choline to Raji B spectra owing to the cross-linking
of B cell surface immunoglobulin receptors inducing the break-
down of phosphatidyl-choline in the cell membrane [41,42], this
feature was not observed in the primary B cells treated with a dif-
ferent stimulant. Here a significant increase in spectral contribu-
tion from TNF-a was observed, which has been observed
previously [43–45], but which was not observed in Raji-B cells
exposed to ionomycin and PMA. This could be related to the fact
that stimulation with IL-4 & CD40L mimicks the T cell dependent
activation of B lymphocytes and activates the NFjB signalling
pathway which results in the production of TNF-a [46], which is
a more specific form of activation in comparison to ionomycin
and PMA. This exemplifies the conclusion that the differential
mode of action of stimulants are observable spectroscopically.
In the THP-1 monocyte cell line and primary monocytes a num-
ber of spectral features increase markedly in both cell types post
PMA or LPS treatment (Figs. 3D and 6D), particularly those of lipid
origin including phosphatidyl-ethanolamine. The increased levels
of phosphatidyl-choline observed in primary monocytes was not
observed in THP-1 cells. This may be linked to increasing lipid
metabolism, [47,48], or an increase in the presence of leucocyte
lipid bodies in cell signalling and inflammation [9,49]. Previous
studies have demonstrated that monocyte to macrophage differen-
tiation leads to profound changes in lipid metabolism which pre-
pares the cells for phagocytic and inflammatory function
[9,49,50]. The differentiation of monocytic THP-1 cell lines using
PMA has also been shown to result in increased adherence and
lower rates of proliferation [18]. This may contribute to the CLS fit-
ting results showing a decrease in the spectral features of DNA in
the differentiated THP-1 and primary cells, which is corroborated
by a time-course LPS activation study of monocytes conducted
by Topfer et al. [9]. Conversely a decrease in apotransferrin level,
which may be attributed to a decrease in transferrin receptor
(TfR) expression and transferrin binding, was observed in the stim-
ulated THP-1 cells [51,52] but not the primary cell line. Addition-
ally the spectral features of TNF-a increased post PMA treatment
in the THP-1 cell line which align with earlier PMA-induced differ-
entiation studies [53,54], and with the ELISA analysis of the cell
supernatant.
In the second observation the spectral profiles of stimulated
PBMCs are discriminated when compared to purified stimulated
Fig. 5. CD40L and IL-4 treatment of B lymphocytes caused an increase in CD69 expression. (A) The overlay histogram plot shows the expression of CD69 in untreated (green
line) and treated cells (black line). (B) MFI produced by CD69 expression of untreated and treated B lymphocytes. Data is normalised to untreated cells and is expressed ± SD
(n = 3). (C) Mean and standard deviation of Raman spectra of untreated and CD40L & IL-4 treated B lymphocytes. (D) Scatter plot of PCA-LDA scores of untreated control and
CD40L & IL-4 treated B lymphocytes. In (D), each symbol represents a Raman spectra recorded from an individual cell of each group, with each group being denoted by a
symbol as shown in the legend. The black line in (D) indicates the hyperplane separating the two groups. (E) Normalised component fit of pure reference molecules from CLS
fitting of Raman spectra of untreated and IL-4 & CD40L treated B lymphocytes. Data is normalised to untreated cells and is expressed ± SE (n = 3). Significance is shown in (E)
by (*) and indicates a significance of *p < 0.05 and ***p < 0.0001.
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Fig. 7. PHA treatment of PBMCs causes an increase in CD69 expression. (A) The overlay histogram plot shows the expression of CD69 on untreated (red line) and PHA treated
PBMCs (black line). (B) MFI produced by CD69 expression on untreated and PHA treated PBMCs. Data is normalised to untreated cells and is expressed ± SD (n = 3). (C) Mean
and standard deviation of Raman spectra of untreated and PHA treated PBMCs, (D) PCA score plot. Percentage label on each axis in (D) indicates the variance associated with
the PC outlined for the discrimination of untreated and PHA treated PBMCs. Covariance ellipses (95% confidence) in (D) are shown for each class. (E) The percentage
component fit of pure reference molecules from CLS fitting of Raman spectra of untreated and PHA treated PBMCs. Data is normalised to untreated PBMCs and is
expressed ± SE (n = 3). Significance is shown in (E) by *** and indicates a significance of p < 0.0001.
Fig. 6. (A) LPS (0.1 lg/ml) treatment of monocytes caused an increase in human TNF-a release. Data is expressed ± SD (n = 2). (B) Mean and standard deviation of Raman
spectra of untreated and LPS treated monocytes. (C) PCA score plot of Raman spectra of untreated and LPS treated monocytes. Percentage label on each axis in (C) indicates the
variance associated with the PC outlined for the discrimination of untreated and LPS treated monocytes. Covariance ellipses (95% confidence) in (C) are shown for each class.
(D) Normalised component fit of pure reference molecules from CLS fitting of Raman spectra of untreated and LPS treated monocytes. Data is normalised to untreated
monocytes and is expressed ± SE (n = 3). Significance is shown in (D) by (*) and indicates a significance of *p < 0.05 and ***p < 0.0001.
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leucocyte subtypes. This implies that the complex interplay of sig-
nalling between leucocytes serves to alter their overall spectral sig-
nal when they are mixed together as compared to when immune
cells subtypes are purified. Spectral fitting of PHA-stimulated
PBMCs suggested elevated contributions from proteinase-K, car-
bonic anhydrase and TNF-a and decreased contributions from
DNA, RNA, lectin and histone. While there are elements of these
observations which align with those seen in the PHA stimulated
Jurkat T cell line, the increased contribution from TNF-a, which
has been observed previously in PHA stimulated PBMCs [55,56],
suggests the involvement of macrophages which may imply T cell
interaction with monocytes post-stimulation. T cell activation is
confirmed via the ~6-fold change in CD69 expression within the
sample. Stimulation of PBMCs with LPS resulted in a ~4-fold
increase in the levels of secreted TNF-a, confirming monocyte acti-
vation/differentiation to macrophages. Spectrally this resulted in a
decreased spectral contribution from DNA and histone (Fig. 8D),
which aligns with data from studies of Jurkat T cell and Raji B cell
lines, and an elevated level of apotransferrin and arachidonic acid
does not align with results from THP-1 cell line stimulation. This
increase in apotransferrin is also seen in Fig. 1E and previous stud-
ies [33,34] and suggests it originates in paracrine stimulation of T
cells.
5. Conclusion
Results reported here demonstrated the potential of Raman
spectroscopy to detect biochemical changes occurring during the
in-vitro activation of immune cell lines and ex-vivo activation of
human immune cells by external stimulants. The CLS fitting anal-
ysis suggested a panel of pure reference molecules that may be
involved in the activation of immune cells. Further calibration of
this approach is warranted. Thus, this study has laid a foundation
to understand the biomolecular changes occurring during an acti-
vatory/inflammatory model using treatment of cells isolated from
healthy individuals.
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